Medifast, Inc. Announces Third Quarter 2019 Results

Go back to Medifast, Inc. Announces Third Quarter 2019 Results

Medifast (MED) Misses Q3 EPS by 2c, Q4 Guidance Falls Well Short of Consensus

November 7, 2019 4:28 PM EST

Medifast (NYSE: MED) reported Q3 EPS of $1.32, $0.02 worse than the analyst estimate of $1.34. Revenue for the quarter came in at $190.1 million versus the consensus estimate of $195.17 million.

GUIDANCE:

Medifast sees Q4 2019 EPS of $1.03-$1.13, versus the consensus of $2.05. Medifast sees Q4... More